Götte M - Search Results

1

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.

Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M. Ibrahim SA, et al. Among authors: gotte m. Mol Cancer. 2017 Mar 7;16(1):57. doi: 10.1186/s12943-017-0621-z. Mol Cancer. 2017. PMID: 28270211 Free PMC article.

2

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.

Radke I, Götte M, Kersting C, Mattsson B, Kiesel L, Wülfing P. Radke I, et al. Among authors: gotte m. Br J Cancer. 2006 Aug 7;95(3):347-54. doi: 10.1038/sj.bjc.6603261. Epub 2006 Jul 11. Br J Cancer. 2006. PMID: 16832410 Free PMC article.

3

Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

Götte M, Yip GW. Götte M, et al. Cancer Res. 2006 Nov 1;66(21):10233-7. doi: 10.1158/0008-5472.CAN-06-1464. Cancer Res. 2006. PMID: 17079438 Review.

4

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.

Götte M, Kersting C, Radke I, Kiesel L, Wülfing P. Götte M, et al. Breast Cancer Res. 2007;9(1):R8. doi: 10.1186/bcr1641. Breast Cancer Res. 2007. PMID: 17244359 Free PMC article.

5

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi LH, Sibrowski W, Wülfing P, Kiesel L, Yip GW, Götte M. Nikolova V, et al. Among authors: gotte m. Carcinogenesis. 2009 Mar;30(3):397-407. doi: 10.1093/carcin/bgp001. Epub 2009 Jan 6. Carcinogenesis. 2009. PMID: 19126645

6

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.

Fischgräbe J, Götte M, Michels K, Kiesel L, Wülfing P. Fischgräbe J, et al. Among authors: gotte m. Int J Cancer. 2010 Aug 1;127(3):696-706. doi: 10.1002/ijc.25076. Int J Cancer. 2010. PMID: 19960438 Free article.

7

miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.

Götte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M, Ibrahim SA, Peddibhotla S, Teng YH, Low JY, Ebnet K, Kiesel L, Yip GW. Götte M, et al. Oncogene. 2010 Dec 16;29(50):6569-80. doi: 10.1038/onc.2010.386. Epub 2010 Sep 6. Oncogene. 2010. PMID: 20818426

8

MicroRNAs in breast cancer pathogenesis.

Götte M. Götte M. Minerva Ginecol. 2010 Dec;62(6):559-71. Minerva Ginecol. 2010. PMID: 21079577 Review.

9

The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.

Götte M, Greve B, Kelsch R, Müller-Uthoff H, Weiss K, Kharabi Masouleh B, Sibrowski W, Kiesel L, Buchweitz O. Götte M, et al. Int J Cancer. 2011 Oct 15;129(8):2042-9. doi: 10.1002/ijc.25856. Epub 2011 Mar 4. Int J Cancer. 2011. PMID: 21165952 Free article.

10

Flow cytometry in cancer stem cell analysis and separation.

Greve B, Kelsch R, Spaniol K, Eich HT, Götte M. Greve B, et al. Among authors: gotte m. Cytometry A. 2012 Apr;81(4):284-93. doi: 10.1002/cyto.a.22022. Epub 2012 Feb 6. Cytometry A. 2012. PMID: 22311742 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

516 results

Search Page